Logo for Milestone Pharmaceuticals Inc

Milestone Pharmaceuticals Investor Relations Material

Latest events

Logo for Milestone Pharmaceuticals Inc

Investor Update

Milestone Pharmaceuticals
Logo for Milestone Pharmaceuticals

Q1 2025

14 May, 2025
Logo for Milestone Pharmaceuticals

Q4 2024

13 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Milestone Pharmaceuticals Inc

Access all reports
Milestone Pharmaceuticals Inc. is a biopharmaceutical company focused on developing cardiovascular therapies. The company specializes in the research and development of treatments for episodic cardiovascular conditions, aiming to provide rapid and effective symptom relief. Its lead drug candidates target conditions such as paroxysmal supraventricular tachycardia (PSVT) and other heart-related disorders. The company is headquartered in Montreal, Canada, and its shares are listed on the NASDAQ.